ALZHEIMER'S DISEASE
Clinical trials for ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's drug trial extension halted after safety monitoring
Disease control TerminatedThis study aimed to evaluate the long-term safety and effectiveness of the experimental drug AL002 in people with early Alzheimer's disease. It was an extension study for 197 participants who had completed a previous AL002 trial. The study was terminated, and its primary focus wa…
Matched conditions: ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Alzheimer's drug extension study halted after 12 patients
Disease control TerminatedThis study aimed to test the long-term safety and effectiveness of an oral medication called SPG302 for people with mild-to-moderate Alzheimer's disease. It was an extension of a previous trial, allowing participants to continue taking the drug for up to one year while monitoring…
Matched conditions: ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC